Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
Clinical trial NCT02187172 · COMPLETED
Trial details
- NCT number
- NCT02187172
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2018-09-11
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.